Skip to search formSkip to main contentSkip to account menu

Spasmex

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A 4-month course of spasmex (15 mg three times a day) was conducted in 57 females (age 18-69 years, mean age 48 years) suffering… 
2010
2010
The analysis of 58 cases of overactive bladder has shown that detrusor activity is not linked with clinical symptoms but is… 
2007
2007
: The study included 62 patients (30 males and 32 females, age 19-80 years, duration of the disease 2-28 years) with… 
2007
2007
The study included 62 patients (30 males and 32 females, age 19-80 years, duration of the disease 2-28 years) with vertebrogenic… 
2007
2007
Non-invasive uroflowmetric monitoring in females with combined incontinence has demonstrated that hyperactive urinary bladder and… 
2005
2005
The aim of the study was to investigate safety and efficacy of spasmex (trospium chloride) in patients with idiopathic and… 
2004
2004
Efficiency of interstitial cystitis (IC) treatment of female outpatients is shown. Combined treatment of IC was supplemented with… 
2004
2004
: Efficiency of interstitial cystitis (IC) treatment of female outpatients is shown. Combined treatment of IC was supplemented… 
2004
2004
The drug spasmex (trospium chloride) having an m-cholinolytic and myotropic spasmolytic action has been used for treatment of… 
2003
2003
Overactive urinary bladder (HAUB) is encountered in 16-20% patients with various voiding disorders. Etiologically, detrusor…